JARED LUKE: Open Payments
NPI 1366900607 · FORT WASHINGTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,395 in 157 payments from 20 companies in 2025. Trend: 2023 $2,360 · 2024 $3,070 · 2025 $3,395
Food & beverage: $3,300Education: $95
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 26 | $672 |
| ABBVIE INC. | 28 | $441 |
| LEO Pharma Inc. | 20 | $396 |
| Novartis Pharmaceuticals Corporation | 13 | $265 |
| UCB, Inc. | 9 | $250 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 8 | $199 |
| Lilly USA, LLC | 10 | $183 |
| GENZYME CORPORATION | 6 | $181 |
| Galderma Laboratories, L.P. | 11 | $159 |
| Organon LLC | 6 | $123 |
Products named: TREMFYA, ADBRY, DUPIXENT, SKYRIZI, COSENTYX, Bimzelx, RINVOQ, TALTZ.
Industry payments across PA — which companies pay providers there.
